Caloric restriction and metformin selectively improved LKB1-mutated NSCLC tumor response to chemo- and chemo-immunotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Caloric restriction and metformin selectively improved LKB1-mutated NSCLC tumor response to chemo- and chemo-immunotherapy ; volume:43 ; number:1 ; day:2 ; month:1 ; year:2024 ; pages:1-18 ; date:12.2024
Journal of experimental & clinical cancer research ; 43, Heft 1 (2.1.2024), 1-18, 12.2024
- Creator
-
Ndembe, Gloriana
Intini, Ilenia
Moro, Massimo
Grasselli, Chiara
Panfili, Andrea
Panini, Nicolò
Bleve, Augusto
Occhipinti, Mario
Borzi, Cristina
Garassino, Marina Chiara
Marabese, Mirko
Canesi, Simone
Scanziani, Eugenio
Sozzi, Gabriella
Broggini, Massimo
Ganzinelli, Monica
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-023-02933-5
- URN
-
urn:nbn:de:101:1-2024031408574489045522
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ndembe, Gloriana
- Intini, Ilenia
- Moro, Massimo
- Grasselli, Chiara
- Panfili, Andrea
- Panini, Nicolò
- Bleve, Augusto
- Occhipinti, Mario
- Borzi, Cristina
- Garassino, Marina Chiara
- Marabese, Mirko
- Canesi, Simone
- Scanziani, Eugenio
- Sozzi, Gabriella
- Broggini, Massimo
- Ganzinelli, Monica
- SpringerLink (Online service)
Other Objects (12)
Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy
Dual Synergistic Tumor‐Specific Polymeric Nanoparticles for Efficient Chemo‐Immunotherapy
Tumor microenvironment-responsive metal nanotherapeutics for breast cancer chemo-/immunotherapy
Dual‐Targeted Lipid Nanotherapeutic Boost for Chemo‐Immunotherapy of Cancer
Tumor microenvironment-responsive spherical nucleic acid nanoparticles for enhanced chemo-immunotherapy
Chemo-immunotherapy in advanced esophageal squamous cell carcinoma: present and future
Enhancing Cancer Chemo‐Immunotherapy: Innovative Approaches for Overcoming Immunosuppression by Functional Nanomaterials
Biomaterial-based scaffold for in situ chemo-immunotherapy to treat poorly immunogenic tumors
Losartan-based nanocomposite hydrogel overcomes chemo-immunotherapy resistance by remodeling tumor mechanical microenvironment
CHEMo unleserlich
CHeMO.
Chemo WDB
Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy
Dual Synergistic Tumor‐Specific Polymeric Nanoparticles for Efficient Chemo‐Immunotherapy
Tumor microenvironment-responsive metal nanotherapeutics for breast cancer chemo-/immunotherapy
Dual‐Targeted Lipid Nanotherapeutic Boost for Chemo‐Immunotherapy of Cancer
Tumor microenvironment-responsive spherical nucleic acid nanoparticles for enhanced chemo-immunotherapy
Chemo-immunotherapy in advanced esophageal squamous cell carcinoma: present and future
Enhancing Cancer Chemo‐Immunotherapy: Innovative Approaches for Overcoming Immunosuppression by Functional Nanomaterials
Biomaterial-based scaffold for in situ chemo-immunotherapy to treat poorly immunogenic tumors
Losartan-based nanocomposite hydrogel overcomes chemo-immunotherapy resistance by remodeling tumor mechanical microenvironment
CHEMo unleserlich
CHeMO.
Chemo WDB
Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy
Dual Synergistic Tumor‐Specific Polymeric Nanoparticles for Efficient Chemo‐Immunotherapy
Tumor microenvironment-responsive metal nanotherapeutics for breast cancer chemo-/immunotherapy
Dual‐Targeted Lipid Nanotherapeutic Boost for Chemo‐Immunotherapy of Cancer
Tumor microenvironment-responsive spherical nucleic acid nanoparticles for enhanced chemo-immunotherapy
Chemo-immunotherapy in advanced esophageal squamous cell carcinoma: present and future
Enhancing Cancer Chemo‐Immunotherapy: Innovative Approaches for Overcoming Immunosuppression by Functional Nanomaterials
Biomaterial-based scaffold for in situ chemo-immunotherapy to treat poorly immunogenic tumors
Losartan-based nanocomposite hydrogel overcomes chemo-immunotherapy resistance by remodeling tumor mechanical microenvironment
CHEMo unleserlich
CHeMO.